EMA Takes Further Action in Ongoing Review of Tainted'Sartans'EMA Takes Further Action in Ongoing Review of Tainted'Sartans '
The European Medicines Agency (EMA) has placed Zheijiang Huahai Pharmaceuticals under increased supervision and stopped Aurobindo Pharma from supplying irbesartan to the European Union.News Alerts (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 15, 2018 Category: Pathology Tags: Cardiology News Alert Source Type: news

AIMS: Irbesartan Slows Marfan's Aortic Dilatation, Lower BP Key? AIMS: Irbesartan Slows Marfan's Aortic Dilatation, Lower BP Key?
Also, should beta-blockers be added to angiotensin receptor blockade in Marfan syndrome? It's possible there may be synergy between the two,'but we didn't see any sign of that,'researchers say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 5, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

ESC: Irbesartan Slows Aortic Dilation in Marfan Syndrome
(MedPage Today) -- ARB therapy yielded 30% reduction in growth rate (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 28, 2018 Category: Cardiology Source Type: news

Irbesartan Generic Tablets (irbesartan) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 11, 2017 Category: Drugs & Pharmacology Source Type: news

The 'Obamacare' Deadline Is Approaching. Here's What You Need to Know Before Signing Up
By Lacie Glover Here's one resolution you should check off early in the year: choosing a health plan if you don't already have one. The deadline to buy a plan under the Affordable Care Act mandate is Jan. 31. If you don't choose a plan by the deadline and pay the first payment when it's due, you won't be able to get coverage this year, with few exceptions. If you lack health coverage for more than three full, consecutive calendar months in any year, you could have to pay a tax penalty. There's a good chance that "Obamacare" will be repealed or revised in 2017, but it's still in place now, so the...
Source: Healthy Living - The Huffington Post - January 3, 2017 Category: Consumer Health News Source Type: news

Avalide (Irbesartan-Hydrochlorothiazide) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 12, 2016 Category: Drugs & Pharmacology Source Type: news

Irbesartan and Hydrochlorothiazide Tablets USP (New - Discontinuation)
Updated Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - November 18, 2016 Category: Drugs & Pharmacology Source Type: news

Avapro (Irbesartan) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 20, 2016 Category: Drugs & Pharmacology Source Type: news

Global Health: Common Blood-Pressure Drug May Work on Malaria, Too
Giving malaria victims a common blood-pressure drug along with regular treatment may save help lives, a mouse study suggests. (Source: NYT Health)
Source: NYT Health - September 19, 2016 Category: Consumer Health News Authors: DONALD G. McNEIL Jr. Tags: Malaria irbesartan Avapro Journal of Clinical Investigation Rodriguez, Ana Source Type: news

Gene expression analysis points metastatic CRC patient to successful irbesartan therapy
medwireNews: A patient with recurrent metastatic colorectal cancer has been successfully treated with the angiotensin receptor blocker irbesartan, researchers report. (Source: MedWire News)
Source: MedWire News - February 25, 2016 Category: Consumer Health News Tags: Colorectal cancer Source Type: news

Diabetics Taking Certain Blood Pressure Drugs At Lower Risk Of Heart Disease
Two drugs, telmisartan and valsartan, which are used to reduce blood pressure in people with diabetes, are associated with a lower risk of hospitalization for heart attack, stroke or heart failure, according to a study published in CMAJ (Canadian Medical Association Journal). For people with type 2 diabetes, disease-related vascular illnesses are the main causes of death. Angiotensin-receptor blockers including telmisartan, valsartan, candesartan, irbesartan and losartan, are generally used interchangeably to control blood pressure... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 10, 2013 Category: Consumer Health News Tags: Hypertension Source Type: news

Two ARBs Lower Risk of CVD Complications in DiabeticsTwo ARBs Lower Risk of CVD Complications in Diabetics
Compared with irbesartan, the use of telmisartan and valsartan lowered the risk of hospital admission for MI, stroke, or heart failure by 15% and 14%, respectively. The reduction was driven primarily by a reduction in the risk of heart-failure hospitalizations. Heartwire (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 8, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news

Telmisartan, valsartan lower risk of CVD complications in diabetics
Compared with irbesartan, the use of telmisartan and valsartan lowered the risk of hospital admission for MI, stroke, or heart failure by 15% and 14%, respectively. The reduction was driven primarily by a reduction in the risk of heart-failure hospitalizations. (Source: theHeart.org)
Source: theHeart.org - July 8, 2013 Category: Cardiology Source Type: news